This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02645/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02645/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02645/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02645/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02645/identifier/pdb/

Statements

Subject Item
n2:DB02645
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB02645 n12:DB02645
dcterms:title
3,4-Epoxybutyl-Alpha-D-Glucopyranoside
adms:identifier
n4:3672483 n8:DB02645 n11:46506071 n13:EBG n14:46936445
n6:IUPAC-Name
n7:271B4AD0-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B4AD6-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B4AD5-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B4AD2-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B4AD3-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B4AD4-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4ACE-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4ACC-363D-11E5-9242-09173F13E4C5 n7:271B4ACF-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4ACD-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4ADC-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4ADD-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B4AD7-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4AD8-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4ADA-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4AD9-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4ADB-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B4AE2-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B4AE4-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B4AE5-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4AE1-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4AE0-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B4AE3-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4AD1-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B4ADE-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4ADF-363D-11E5-9242-09173F13E4C5